UNSPSC 12161505: Intercalating agents

UNSPSC 12161505 Intercalating agents, a Commodity code, appears in state and local drug-testing and forensic-laboratory solicitations where public health and criminal-justice agencies procure specimen-screening materials, confirmatory testing kits, and diagnostic reagents. The recent opportunities show that state and local governments use this code to buy immunoassay screening supplies, therapeutic drug monitoring test kits (including Clozapine monitoring), and forensic DNA amplification chemistry for laboratory operations. Issuing bodies include county community-supervision departments, state police forensic labs, county health-care services, state mental-health agencies, and public-health departments. The work spans clinical laboratory services with multiple test modalities, offender drug-screening programs with both immunoassay and confirmation testing, and specialized forensic and pharmaceutical monitoring applications.

Activity concentrates in Texas, Oregon, Mississippi, California, and the District of Columbia, with recent solicitations weighted toward Texas and Oregon. Representative opportunities include Collin County Community Supervision and Corrections Department (RFP 2026-327 for offender specimen collection and drug testing services, approximately 25,031 tests annually on a per-test pricing model, contract value $600,000, proposals due July 23, 2026); Oregon State Police (sole-source notice for Promega PowerPlex Y23 forensic DNA amplification kits and supplies, estimated five-year value $250,000, posted July 23, 2026); Mississippi Department of Mental Health (sole-source notice for FDA-cleared Clozapine test kits, posted September 16, 2026); San Bernardino County Department of Public Health (ITB for laboratory supplies including culture media, stains, reagents, and diagnostic test materials, proposals due July 31, 2026); and Collin County Health Care Services (IFB for certified medical laboratory provider services including over 200 test types, estimated annual value $70,000, response deadline October 2, 2025). Sole-source determinations appear frequently, reflecting specialized validation requirements and existing equipment-compatibility constraints in forensic and clinical settings.